Baolei Guo | Vascular Surgery | Best Researcher Award

Posted on by ScienceFather
Assoc Dr.  Department of Vascular Surgery, Zhongshan Hospital Fudan University, china

Dr. Baolei Guo is an Associate Professor at Fudan University and an Attending Doctor in the Department of Vascular Surgery at Zhongshan Hospital, Fudan University, where he has served since 2017. He earned his MD and Ph.D. from Shanghai Medical College, Fudan University, and has been involved in numerous research projects, focusing on vascular surgery, medical imaging, and device development. Dr. Guo has received multiple prestigious grants, including the Health Youth Talent Training Program and the National Natural Science Foundation of China Youth Fund. His work is published in top journals, highlighting innovations in vascular surgery and imaging techniques.

 

Professional Profiles:

Scopus

 

🏢 Employment

Associate Professor, Fudan University (03/2023-present)Attending Doctor, Department of Vascular Surgery, Zhongshan Hospital Fudan University (10/2020-present)Resident Doctor, Department of Vascular Surgery, Zhongshan Hospital Fudan University (07/2017-10/2020)Resident Doctor, Department of Anesthesiology, Zhongshan Hospital Fudan University (07/2013-09/2014)

🎓 Education Experience

Shanghai Medical College, Fudan UniversityMD, PhD (2014-2017)Department of Chemical Engineering, Imperial College LondonPhD Visiting Scholar (2016-2017)Shanghai Medical College, Fudan UniversityMSc (2010-2013)Hebei Chengde Medical CollegeBSc (2005-2010)

💰 Current Grants

Health Youth Talent Training Program of Shanghai Municipal Health Commission2022YQ013, 2023/01-2025/12, 300,000¥, PIShanghai “Medical Academy Rising Star” Youth Medical Talent Training Funding ProgramR2021-016, 2022/01-2024/12, 100,000¥, PI

Dr. Baolei Guo for the Best Researcher Award

Strengths for the Award:

  1. Extensive Research and Publications: Dr. Baolei Guo has an impressive record of publications in prestigious journals like European Journal of Vascular and Endovascular Surgery, Journal of Vascular Surgery, and IEEE Transactions on Biomedical Engineering. His research primarily focuses on vascular surgery, particularly on aortic dissection, endovascular repair, and imaging technologies, which are highly relevant to advancements in vascular health.
  2. Leadership in Research Projects: As the Principal Investigator (PI) for multiple significant grants, Dr. Guo has demonstrated strong leadership and innovation in his field. His involvement in pioneering projects such as the study of PET-CT/4D-PCMR combined with IVUS multimodal imaging technology and the development of plaque surface cleaning devices during CAS highlights his commitment to improving surgical outcomes and patient care.
  3. International Collaboration and Recognition: Dr. Guo’s international experience as a visiting scholar at Imperial College London, coupled with his collaboration with researchers globally, underlines his recognition in the academic community. This global perspective enhances the impact and applicability of his research in diverse healthcare settings.
  4. Clinical Expertise: With extensive clinical experience as an attending and resident doctor in vascular surgery, Dr. Guo bridges the gap between research and practice. His work directly influences clinical procedures, making his research highly translational and impactful.
  5. Innovative Approach: Dr. Guo’s research integrates advanced imaging techniques and computational modeling, contributing to the development of cutting-edge technologies in vascular surgery. His work on creating a swine model for type B aortic dissection and his studies on the hemodynamics of vascular diseases exemplify his innovative approach.

Areas for Improvement:

  1. Broader Dissemination of Research: While Dr. Guo has a robust publication record, expanding his reach through more public-facing platforms, such as conferences, seminars, or involvement in international committees, could further enhance his visibility and influence in the global research community.
  2. Collaboration with Industry: Engaging with the medical device industry for the translation of his research into commercially viable products could significantly boost the practical application of his work. This would also open avenues for securing additional funding and enhancing the real-world impact of his research.
  3. Diversity of Research Topics: While Dr. Guo has established expertise in vascular surgery, exploring related fields such as cardiovascular biomaterials or regenerative medicine could diversify his research portfolio and contribute to a more comprehensive approach to vascular health.

 

✍️Publications Top Note :

  • Fauzi, M.F.M., Johari, N.H., Mokhtarudin, M.J.M., Yusoff, B.M., Guo, B.
    Fluid-Structure Interaction Modelling of Blood Flow in Peripheral Arterial Disease.
    Journal of Advanced Research in Fluid Mechanics and Thermal Sciences, 2024, 119(1), pp. 117–133.
  • Gao, P., Guo, B., Zhang, M., Dai, X., Liu, H.
    Modeling Method of Aortic Homeostasis Considering Three-Dimensional Residual Deformation.
    Yiyong Shengwu Lixue/Journal of Medical Biomechanics, 2024, 39(3), pp. 510–517.
  • Zhang, S., Guo, B., Hu, M.
    Some Reflections on Investigating the Long Term Healthy Life Quality of Acute Type B Aortic Dissection Patients.
    European Journal of Vascular and Endovascular Surgery, 2024, 67(3), pp. 524–525.
  • Guo, B., Chen, C., Li, Y., Fu, W., Zhang, W.W.
    Principles of Optimal Antithrombotic Therapy for Iliac Venous Stenting (POATIVES): A National Expert-Based Delphi Consensus Study.
    Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2024, 12(2), 101739.
  • Armour, C., Guo, B., Saitta, S., Dong, Z., Xu, X.Y.
    The Role of Multiple Re-Entry Tears in Type B Aortic Dissection Progression: A Longitudinal Study Using a Controlled Swine Model.
    Journal of Endovascular Therapy, 2024, 31(1), pp. 104–114.
  • Wang, K., Armour, C.H., Guo, B., Dong, Z., Xu, X.Y.
    A New Method for Scaling Inlet Flow Waveform in Hemodynamic Analysis of Aortic Dissection.
    International Journal for Numerical Methods in Biomedical Engineering, 2024.

Conclusion:

Dr. Baolei Guo stands out as a strong candidate for the Best Researcher Award due to his significant contributions to vascular surgery research, his leadership in innovative projects, and his integration of clinical expertise with research. By expanding his research dissemination efforts and fostering collaborations with industry, Dr. Guo could further elevate his impact in the field. His work not only advances scientific knowledge but also directly improves patient outcomes, making him a deserving contender for this prestigious award.

Dr. Yongyue Wei | based Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Yongyue Wei | based Medicine | Best Researcher Award 

Dr. Yongyue Wei , Peking University, China

Dr. Yongyue Wei is academic and researcher in the field of renewable energy, holds a PhD in Bio systems Engineering from Kangwon National University, South Korea. His academic journey has been marked by a profound dedication to advancing solar energy technologies, specifically in solar thermal harvesting and its integration into agricultural and architectural applications.

Professional Profiles:

Orcid

Google scholar

Scopus

🎓 Education

Bachelor’s Degree: Yanbian University (2014-2019)MD: Yanbian University (2020-2022)PhD: Yanbian University (2022-present)

💼 Professional Experiences

No Professional Experience Listed🏅 Honors and Awards2024: Best Moderated Poster Presentation Award, Korean Society of CardioMetabolic Syndrome, Asia-Pacific CardioMetabolic Syndrome Congress

🔬 Major Research Interests

Pulmonary Hypertension 🌬️Chronic Stress-Related Diseases 😰Nutrition 🍎Atherosclerosis & Vascular Biology 💓

📖 Publications Top Note :

Rare Variants of Large Effect in BRCA2 and CHEK2 Affect Risk of Lung Cancer
Authors: Y Wang, JD McKay, T Rafnar, Z Wang, MN Timofeeva, P Broderick, Y Wei, et al.
Journal: Nature Genetics 46 (7), 736-741, 2014
Citations: 434
Summary: This study identifies significant rare genetic variants in BRCA2 and CHEK2 that substantially increase the risk of lung cancer, highlighting critical pathways for targeted therapies.

Development and Validation of an Immune Gene-Set Based Prognostic Signature in Ovarian Cancer
Authors: S Shen, G Wang, R Zhang, Y Zhao, H Yu, Y Wei, F Chen
Journal: EBioMedicine 40, 318-326, 2019
Citations: 214
Summary: The research develops a prognostic signature based on immune gene sets, providing a robust tool for predicting ovarian cancer outcomes and personalizing treatment strategies.

Comparison of the Prevalence and Changing Resistance to Nalidixic Acid and Ciprofloxacin of Shigella between Europe–America and Asia–Africa from 1998 to 2009
Authors: B Gu, Y Cao, S Pan, L Zhuang, R Yu, Z Peng, H Qian, Y Wei, L Zhao, et al.
Journal: International Journal of Antimicrobial Agents 40 (1), 9-17, 2012
Citations: 185
Summary: This comparative study examines the resistance patterns of Shigella to nalidixic acid and ciprofloxacin across different continents, shedding light on global antimicrobial resistance trends.

Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy
Authors: Y Wang, H Zhu, X Hou, Z Wang, F Zou, Z Qian, Y Wei, X Wang, L Zhang, et al.
Journal: Journal of the American College of Cardiology 80 (13), 1205-1216, 2022
Citations: 157
Summary: This clinical trial compares the efficacy of left bundle branch pacing with biventricular pacing in cardiac resynchronization therapy, offering new insights for treatment optimization.

Risk Factors and Long-Term Health Consequences of Macrosomia: A Prospective Study in Jiangsu Province, China
Authors: S Gu, X An, L Fang, X Zhang, C Zhang, J Wang, Q Liu, Y Zhang, Y Wei, et al.
Journal: Journal of Biomedical Research 26 (4), 235-240, 2012
Citations: 126
Summary: This prospective study investigates the risk factors for macrosomia and its long-term health impacts, providing valuable data for preventive healthcare strategies.

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
Authors: G Fehringer, P Kraft, PD Pharoah, RA Eeles, N Chatterjee, Y Wei, et al.
Journal: Cancer Research 76 (17), 5103-5114, 2016
Citations: 117
Summary: A genome-wide analysis identifying pleiotropic genetic associations across multiple cancer types, enhancing understanding of common pathways in carcinogenesis.

Gene Control of Tyrosine Kinase TIE2 and Vascular Manifestations of Infections
Authors: CC Ghosh, S David, R Zhang, A Berghelli, K Milam, SJ Higgins, J Hunter, Y Wei, et al.
Journal: Proceedings of the National Academy of Sciences 113 (9), 2472-2477, 2016
Citations: 104
Summary: The study explores the role of TIE2 in vascular responses to infections, providing insights into the mechanisms of vascular diseases and potential therapeutic targets.

Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study
Authors: T Wang, Z Liu, Z Wang, M Duan, G Li, S Wang, W Li, Z Zhu, Y Wei, et al.
Journal: PLoS One 9 (4), e94124, 2014
Citations: 83
Summary: This international study links thrombocytopenia with higher mortality in acute respiratory distress syndrome (ARDS), emphasizing the importance of platelet count monitoring.

Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium
Authors: R Huang, Y Wei, RJ Hung, G Liu, L Su, R Zhang, X Zong, ZF Zhang, et al.
Journal: EBioMedicine 2 (11), 1677-1685, 2015
Citations: 72
Summary: This pooled analysis investigates the associations between smoking, COPD, and small cell lung cancer, underscoring the interconnected risk factors in lung cancer development.

Comprehensive Analyses of m6A Regulators and Interactive Coding and Non-Coding RNAs Across 32 Cancer Types
Authors: S Shen, R Zhang, Y Jiang, Y Li, L Lin, Z Liu, Y Zhao, H Shen, Z Hu, Y Wei, et al.
Journal: Molecular Cancer 20, 1-6, 2021
Citations: 69
Summary: This study comprehensively analyzes m6A regulators and their interactions with coding and non-coding RNAs across multiple cancer types, providing a deeper understanding of epigenetic regulation in cancer.

Prof Dr. Satya Prakash | Functional Biomaterial Award | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Satya Prakash | Functional Biomaterial Award | Best Researcher Award

Prof Dr. Satya Prakash, McGill University, Canada

Prof Dr. Satya Prakash is academic and researcher in the field of renewable energy, holds a PhD in Bio systems Engineering from Kangwon National University, South Korea. His academic journey has been marked by a profound dedication to advancing solar energy technologies, specifically in solar thermal harvesting and its integration into agricultural and architectural applications.

Professional Profiles:

Google scholar

🔬 Research Funding:

Prof. Satya Prakash has secured over 48 funded research grants, demonstrating his ability to attract significant financial support for his research endeavors. Additionally, he currently maintains four active grants, indicating the ongoing relevance and impact of his work.

🏆 Distinguished James McGill Professor Endowment:

This prestigious endowment recognizes Prof. Prakash as an outstanding original researcher of world-class caliber and an international leader in his field. It provides eight years of salary endowment and citation, further cementing his reputation and contributions.

💰 Salary Endowments:

Prof. Prakash holds four salary endowments, including the CIHR New Investigator award and the FRSQ Chercher-Boursier Junior 1 award, which provide substantial financial support and relieve him of teaching and administrative responsibilities, allowing him to focus on research.

🎖️ Recognition and Awards:

With over 27 awards, honors, and recognitions to his name, including the esteemed Academician title from the Royal Society of Canada, Prof. Prakash’s contributions to academia and research are widely celebrated and acknowledged.

📝 Patents and Spin Offs:

Prof. Prakash’s innovative work has led to the development of four successful spin-offs and over 75 approved or pending patents. This demonstrates his commitment to translating research into tangible applications that benefit society and industry.

📊 Citation Metrics (Google Scholar):

Citations: 20,298

h-index: 64

i10-index: 445

Person/Entity 2:

Citations: 8,160

h-index: 39

i10-index: 180

📖 Publications  Top Note :

Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis

Authors: S Westfall, N Lomis, I Kahouli, SY Dia, SP Singh, S Prakash

Published in: Cellular and molecular life sciences, 74, 3769-3787, 2017

Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic …

Authors: ML Jones, CJ Martoni, M Parent, S Prakash

Published in: British Journal of Nutrition, 107 (10), 1505-1513, 2012

Gut microbiota: next frontier in understanding human health and development of biotherapeutics

Authors: S Prakash, L Rodes, M Coussa-Charley, C Tomaro-Duchesneau

Published in: Biologics: targets and therapy, 71-86, 2011

Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial

Authors: ML Jones, CJ Martoni, S Prakash

Published in: European journal of clinical nutrition, 66 (11), 1234-1241, 2012

Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy

Authors: S Prakash, M Malhotra, W Shao, C Tomaro-Duchesneau, S Abbasi

Published in: Advanced drug delivery reviews, 63 (14-15), 1340-1351, 2011

Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model

Authors: W Shao, A Paul, B Zhao, C Lee, L Rodes, S Prakash

Published in: Biomaterials, 34 (38), 10109-10119, 2013

Pallidol, a resveratrol dimer from Cissus pallida

Authors: MA Khan, SG Nabi, S Prakash, A Zaman

Published in: Phytochemistry, 25 (8), 1945-1948, 1986

Seismic performance of circular RC columns subjected to axial force, bending, and torsion with low and moderate shear

Authors: S Prakash, A Belarbi, YM You

Published in: Engineering Structures, 32 (1), 46-59, 2010

Superior cell delivery features of poly (ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules

Authors: T Haque, H Chen, W Ouyang, C Martoni, B Lawuyi, AM Urbanska, …

Published in: Molecular Pharmaceutics, 2 (1), 29-36, 2005

High temperature oxidation studies of detonation-gun-sprayed Cr3C2–NiCr coating on Fe-and Ni-based superalloys in air under cyclic condition at 900° C

Authors: S Kamal, R Jayaganthan, S Prakash

    • Published in: Journal of alloys and compounds, 472 (1-2), 378-389, 2009